Validity evidence supports the use of automated neuropsychological assessment metrics as a screening tool for cognitive impairment in lupus.
Screening for Cognitive Impairment (CI) in Systemic Lupus Erythematosus (SLE) conventionally relies on the American College of Rheumatology (ACR) Neuropsychological Battery (NB), which is not universally available. To develop a more accessible screening approach, we assessed validity of the Automated Neuropsychological Assessment Metrics (ANAM). Using the ACR-NB as the gold standard for CI classification, the objectives were to (a) measure overall discriminative validity of the ANAM for CI vs. non-CI, (b) identify ANAM subtests and scores that best differentiate CI from non-CI patients, and (c) derive an ANAM composite indices and cut-offs. 211 consecutive adult, female/male SLE patients were administered the ANAM and NB. (a) For overall discriminative validity of the ANAM, we compared CI vs non-CI patients on 4 scores. (b) Six ANAM models using different scores were developed and the most discriminatory subtests were selected using logistic regression analyses. The Area Under the receiver operating characteristics Curve (AUC) was calculated to establish ANAM validity against NB. (c) ANAM composite indices and cut-offs were derived for the best model(s), and sensitivities/specificities calculated. Patients with non-CI performed better on most ANAM subtests, supporting ANAM's discriminative validity. CI could be accurately identified by selected ANAM subtests with top models demonstrating excellent AUCs of 81% and 84%. Derived composite indices and cut-offs demonstrated sensitivity of 78-80% and specificity of 70%. This study provides support for ANAM's discriminative validity for CI and utility for cognitive screening in adult SLE. Derived composite indices and cut-offs enhance clinical applicability.